Gene · 8505
Papers1,648
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,648
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours. | Int J Mol Sci | 2023 | 37686260 | PubTator, text mining | PubMed |
| PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy. | Cell Rep Med | 2023 | 37683650 | PubTator, text mining | PubMed |
| A new wave of innovations within the DNA damage response. | Signal Transduct Target Ther | 2023 | 37679326 | PubTator, text mining | PubMed |
| The interplay of TARG1 and PARG protects against genomic instability. | Cell Rep | 2023 | 37676774 | PubTator, text mining | PubMed |
| Using TLC-MALDI-TOF to Interrogate In Vitro Peptidyl Proximal Preferences of PARP14 and Glycohydrolase Specificity. | Molecules | 2023 | 37630315 | PubTator, text mining | PubMed |
| The Role of Poly(ADP-ribose) Polymerase 1 in Nuclear and Mitochondrial Base Excision Repair. | Biomolecules | 2023 | 37627260 | PubTator, text mining | PubMed |
| The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. | NAR Cancer | 2023 | 37609662 | PubTator, text mining | PubMed |
| Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance. | Front Pharmacol | 2023 | 37601042 | PubTator, text mining | PubMed |
| Absence of mitochondrial SLC25A51 enhances PARP1-dependent DNA repair by increasing nuclear NAD+ levels. | Nucleic Acids Res | 2023 | 37587695 | PubTator, text mining | PubMed |
| Extrachromosomal Telomeres Derived from Excessive Strand Displacements. | bioRxiv | 2023 | 37577643 | PubTator, text mining | PubMed |
| Circular RNA PARG adjusts miR-140-3p to influence progression in sepsis. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37571893 | PubTator, text mining | PubMed |
| Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs. | Molecules | 2023 | 37570820 | PubTator, text mining | PubMed |
| PARPs and ADP-Ribosylation in Chronic Inflammation: A Focus on Macrophages. | Pathogens | 2023 | 37513811 | PubTator, text mining | PubMed |
| Mechanisms of PARP-Inhibitor-Resistance in BRCA-Mutated Breast Cancer and New Therapeutic Approaches. | Cancers (Basel) | 2023 | 37509303 | PubTator, text mining | PubMed |
| Unravelling the Role of PARP1 in Homeostasis and Tumorigenesis: Implications for Anti-Cancer Therapies and Overcoming Resistance. | Cells | 2023 | 37508568 | PubTator, text mining | PubMed |
| Abr, a Rho-regulating protein, modulates osteoclastogenesis by enhancing lamellipodia formation by interacting with poly(ADP-ribose) glycohydrolase. | Mol Biol Rep | 2023 | 37507586 | PubTator, text mining | PubMed |
| PARP14 is a writer, reader, and eraser of mono-ADP-ribosylation. | J Biol Chem | 2023 | 37507011 | PubTator, text mining | PubMed |
| The Roles of Exosomes in Ovarian Cancer Chemo-resistance. | J Cancer | 2023 | 37497408 | PubTator, text mining | PubMed |
| Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity. | EMBO J | 2023 | 37492888 | PubTator, text mining | PubMed |
| A HUWE1 defect causes PARP inhibitor resistance by modulating the BRCA1-∆11q splice variant. | Oncogene | 2023 | 37491606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8505/papers?page=8